Overall, our study demonstrates that Neuro-PASC patients have elevated T cell responses to the C-terminal region of Nucleocapsid protein, impaired N-specific CD8+ memory responses, and elevated N-specific IL-6 production compared with convalescent controls. The gene discussed is CD8A; the disease is long COVID-19.